SPOTLIGHT: WHO: New sleep meds little better than old

A WHO analysis finds that new-generation sleep meds like Ambien and Lunesta have side effects that are "nearly as problematic" as older drugs such as Halcion, which was banned in some countries. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.